Barrett Esophagus in Patients with Erosive Esophagitis

Approximately 9% of patients with EE had BE diagnosed during subsequent upper endoscopy.

Endoscopic screening for Barrett esophagus (BE) has become a standard of care, despite the paucity of data demonstrating any survival benefit (JW Gastroenterol Apr 18 2008). Concern exists that BE could be missed during the screening of patients with erosive esophagitis (EE), given that BE diagnosis depends on histologic confirmation of specialized columnar metaplasia. In this retrospective study, investigators described the proportion of patients with EE who later received a diagnosis of BE during upper endoscopic evaluation.

During a 10-year period at two California hospitals, 102 individuals with EE (mostly older white men) underwent upper endoscopy for any indication. Thirty-four percent of patients were receiving proton-pump inhibitors …

Reviewing Author

David A. Johnson, MD

Disclosures

Consultant/Advisory boardMedscape/WebMD; Pfizer; CRH Medical Corporation; Aries

EquityCRH Medical Corporation

Editorial boardsMedscape Gastroenterology

Leadership positions in professional societiesAmerican College of Gastroenterology Research Institute Board of Directors